Suven Life Sciences Limited

Quick facts

Phase 2 pipeline

• Samelisant · Other
• SUVN-502

Phase 1 pipeline

• SUVN-911
• SUVN-I6107

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Suven Life Sciences Limited portfolio CI brief
• Suven Life Sciences Limited pipeline updates RSS